1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. オファー別スニペット
3.2. 適応症別スニペット
3.3. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 技術の進歩と高齢化
4.1.1.2. 医療費の上昇と政府の支援
4.1.2. 阻害要因
4.1.2.1. 労働力不足と規制上の課題
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. ロシア・ウクライナ戦争の影響分析
5.6. DMI意見
6. オファー別
6.1. 導入
6.1.1. 市場規模分析と前年比成長率分析（%）, オファリング別
6.1.2. 市場魅力度指数（オファリング別
6.2. サービス
6.2.1. サービス紹介
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.2.1. 医師のプライマリケア
6.2.2.2. 介護
6.2.2.3. 理学/作業/言語療法
6.2.2.4. 栄養サポート
6.2.2.5. 未熟練者ケア
6.2.2.6. その他
6.3. 製品
6.3.1. 製品紹介
6.3.2. 市場規模分析と前年比成長率分析(%)
6.3.2.1. 治療用製品
6.3.2.2. 検査、スクリーニング、モニタリング製品
6.3.2.3. モビリティケア製品
6.3.2.4. その他
7. 適応症別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（％）、適応症別
7.1.2. 市場魅力度指数、適応症別
7.2. がん*市場
7.2.1. 序論
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 神経疾患
7.4. 運動障害
7.5. 糖尿病
7.6. 心血管障害
7.7. その他
8. 持続可能性分析
8.1. 環境分析
8.2. 経済分析
8.3. ガバナンス分析
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, オファリング別
9.2.4. 市場規模分析および前年比成長率分析（%）、適応症別
9.2.5. 市場規模分析および前年比成長率分析（%）, 国別
9.2.5.1. 米国
9.2.5.2. カナダ
9.2.5.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, オファリング別
9.3.4. 市場規模分析および前年比成長率分析（%）、適応症別
9.3.5. 市場規模分析および前年比成長率分析（%）, 国別
9.3.5.1. ドイツ
9.3.5.2. イギリス
9.3.5.3. フランス
9.3.5.4. イタリア
9.3.5.5. スペイン
9.3.5.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, オファリング別
9.4.4. 市場規模分析および前年比成長率分析（%）、適応症別
9.4.5. 市場規模分析および前年比成長率分析（%）, 国別
9.4.5.1. ブラジル
9.4.5.2. アルゼンチン
9.4.5.3. その他の南米地域
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, オファリング別
9.5.4. 市場規模分析および前年比成長率分析（%）、適応症別
9.5.5. 市場規模分析および前年比成長率分析（%）, 国別
9.5.5.1. 中国
9.5.5.2. インド
9.5.5.3. 日本
9.5.5.4. オーストラリア
9.5.5.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, オファリング別
9.6.4. 市場規模分析および前年比成長率分析（%）、適応症別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11.1. Omron Healthcare, Inc*
11.1. オムロンヘルスケア
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. 3M
11.3. Air Liquide
11.4. B. Braun Melsungen AG
11.5. Linde plc
11.6. GE HealthCare
11.7. Koninklijke Philips N.V.,
11.8. Dickinson and Company
11.9. A&D Company Limited
11.10. Addus HomeCare Corporation.
リストは網羅的ではありません
12. 付録
12.1. 当社とサービスについて
12.2. お問い合わせ
Global Home Healthcare Industry Market reached US$ 269.53 billion in 2023 and is expected to reach US$ 474.25 billion by 2031, growing with a CAGR of 7.32% during the forecast period 2024-2031.
The global home healthcare industry market is expanding rapidly due to the rising demand for in-home care services driven by an aging population and an increased prevalence of chronic diseases. Home healthcare includes a variety of services such as nursing care, physical therapy, telehealth and assistive devices. This care model provides patients with the convenience of receiving medical care at home, which in turn lowers the necessity for hospitalization and reduces healthcare expenses.
The industry's growth is further propelled by the widespread adoption of telemedicine and remote patient monitoring, which have become essential tools for managing patients with chronic conditions like diabetes, heart disease and respiratory disorders. Regulatory frameworks, such as those set by US Centers for Medicare & Medicaid Services (CMS) and the World Health Organization (WHO), have played a crucial role in standardizing quality and safety in-home healthcare services.
Asia-Pacific is becoming one of the fastest growing markets for home healthcare due to the increasing elderly population, adoption of technology and government efforts to decrease hospital congestion. Countries such as Japan, China and India are witnessing a surge in demand for home healthcare services, supported by government policies promoting elderly care at home. Japan, with one of the world's most rapidly aging populations, has seen significant investment in home healthcare technologies.
Dynamics
Technological Advancements and Aging Population
Technological innovations, coupled with the aging global population, are key drivers in the home healthcare market. Advanced healthcare devices such as smart monitors, telehealth platforms and wearable devices are becoming integral to in-home medical care. These technologies aid in the management of chronic conditions, lessen hospital trips and enhance overall efficiency in patient care. For instance, wearable heart monitors can offer healthcare providers instant updates, allowing for prompt interventions as necessary.
The increasing elderly population is another major driver. According to the United Nations (UN), the global number of people aged 80 years or older is expected to triple between 2019 and 2050, increasing from 143 million to 426 million. The increase in this specific demographic leads to a greater need for home healthcare services, as elderly people opt to be cared for in their own homes instead of staying in hospitals for long periods and incurring high healthcare expenses.
Rising Healthcare Costs and Government Support
The increasing expense of healthcare is driving patients and healthcare providers to seek economical options, with home healthcare providing substantial cost savings in comparison to hospital treatment. According to the Centers for Medicare & Medicaid Services (CMS), home healthcare is a cost-effective option for managing chronic diseases and recovering from surgeries, as it is notably cheaper than hospital care. With budget limitations, healthcare systems are gaining more government aid in the form of reimbursement policies and tax incentives to promote the use of home healthcare services.
Furthermore, US Bureau of Labor Statistics predicts a 29% increase in job opportunities within the home healthcare industry from 2020 to 2030, surpassing the average growth rate for all professions and highlighting the sector's increasing significance in healthcare services. Additionally, government efforts like these are essential for driving the market forward, as global healthcare expenditures on home healthcare are expected to increase with a notable growth rate each year. This increase is particularly noticeable in nations with elderly populations and overwhelmed hospital systems.
Workforce Shortages and Regulatory Challenges
Workforce shortages and regulatory hurdles are the key factors that hamper the growth of the home healthcare industry. A shortage of qualified home healthcare workers, including nurses and aides, is placing a strain on service delivery, especially in rural areas. WHO projects a shortfall of 18 million health workers to accelerate universal health coverage by 2030, particularly in low- and lower-middle-income countries, exacerbating the issue of home healthcare.
Additionally, regulatory challenges pose a restraint on market growth. Countries with stringent healthcare regulations may face barriers in terms of reimbursement processes, certification requirements for home healthcare providers and privacy concerns surrounding the use of digital health monitoring tools. These regulatory bottlenecks often slow down the adoption of new technologies and services in home healthcare.
Segment Analysis
The global home healthcare industry market is segmented based on offering, indication and region.
Demand for Assistive Devices and Remote Monitoring Tools
The demand for home healthcare market is driven by the adoption of assistive devices and remote monitoring tools. The devices help manage chronic diseases and enable elderly or disabled individuals to live more independently. According to the United Nations, the global population aged 60 years or over is expected to double by 2050, driving increased demand for devices like mobility aids, oxygen delivery systems and home dialysis equipment.
Telehealth and remote patient monitoring are also experiencing significant demand as they enable healthcare providers to monitor patient’s conditions without the need for in-person visits. Furthermore, advancements in communication technologies and the increasing prevalence of chronic conditions such as diabetes and hypertension also drive the home health market growth. Moreover, these tools reduce the burden on healthcare systems by allowing for continuous monitoring and early intervention, which can help prevent hospital readmissions and improve overall patient outcomes.
Geographical Penetration
Demand for Home-Based Medical Services in North America
North America dominates the global home healthcare market, driven by a strong demand for home-based medical services, particularly for managing chronic diseases like cardiovascular disease (CVD) and cancer. According to the Centers for Disease Control and Prevention (CDC), heart disease accounted for 680,909 deaths in US in 2023, making it the third leading cause of death. With cancer (613,331 deaths) and unintentional injuries (222,518 deaths) also among the top causes, the need for at-home healthcare solutions for chronic disease management has intensified.
US healthcare system is increasingly adopting home healthcare solutions as a cost-effective alternative to hospital-based care. As healthcare costs continue to rise, patients are seeking home-based treatment options for post-surgery recovery and chronic disease management. US government’s support, through reimbursement policies and tax incentives, further drives the adoption of home healthcare technologies and services.
Competitive Landscape
The major global players in the market include Omron Healthcare, Inc, 3M, Air Liquide, B. Braun Melsungen AG, Linde plc, GE HealthCare, Koninklijke Philips N.V., Dickinson and Company, A&D Company Limited and Addus HomeCare Corporation.
Sustainability Analysis
Sustainability is becoming an increasingly important factor in the global home healthcare industry, with a growing emphasis on reducing the environmental impact of medical waste and energy consumption. The adoption of energy-efficient medical equipment and telehealth tools is reducing the healthcare sector's carbon footprint, as digital healthcare technologies are decreasing the reliance on physical infrastructure.
According to the Global Sustainability Council for Healthcare (GSCH), the home healthcare market can contribute significantly to global sustainability goals by reducing the need for hospital infrastructure, thereby decreasing energy consumption and waste generation. Specifically, remote patient monitoring systems and telemedicine help decrease the need for patients to travel and be admitted to the hospital, supporting a more sustainable healthcare system. Furthermore, companies are increasingly focused on designing recyclable and biodegradable medical devices, aligning with global environmental regulations and consumer demand for eco-friendly solutions.
Russia-Ukraine War Impact
The ongoing Russia-Ukraine war has created both direct and indirect challenges for the global home healthcare industry. One of the main impacts has been the disruption of medical device and healthcare supply chains across Europe. Ukraine is an essential provider of electronic parts for medical equipment, including those for home medical care. The conflict has caused disruptions in the supply chain, resulting in shortages and higher prices for medical devices, which has in turn delayed the adoption of home healthcare technologies.
Moreover, with the geopolitical situation resulting in a significant humanitarian crisis, healthcare systems in neighboring countries have been overwhelmed by the influx of refugees. This situation has redirected healthcare resources, including home healthcare services, to crisis management. Furthermore, governments in impacted areas are increasing financial allocation to military expenses, possibly leading to a decrease in funding for healthcare, such as home healthcare initiatives.
By Offering
● Services
o Physician primary care
o Nursing care
o Physical/occupational/speech therapy
o Nutritional support
o Unskilled Care
o Others
● Products
o Therapeutic Products
o Testing, Screening and Monitoring Products
o Mobility Care Products
o Others
By Indication
● Cancer
● Neurological Disorders
● Mobility Disorders
● Diabetes
● Cardiovascular Disorders
● Others
Region
● North America
o US
o Canada
o Mexico
● Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
● South America
o Brazil
o Argentina
o Rest of South America
● Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
● Middle East and Africa
Key Developments
● In June 2023, Amedisys, a leading provider of personalized home health and hospice care, announced its agreement to combine with Optum, a diversified health services company. Amedisys provides specialized care to patients in their homes through over 11.2 million home visits each year. This merger is intended to improve the provision of complete home healthcare services, leading to better patient results and increasing their presence in the expanding home healthcare industry.
● In February 2023, 3M launched a new medical adhesive designed for use with a variety of sensors, health monitors and long-term medical wearables. This strategic move helped 3M broaden its product offering in the home healthcare space, particularly in medical wearables, by catering to the growing demand for remote patient monitoring solutions.
● In November 2022, the Pennant Group, Inc. acquired a Wisconsin-based home health provider to deliver skilled home health and community health services in Kenosha, Wisconsin. This acquisition reflects Pennant’s strategy to strengthen its footprint in the home healthcare market.
Why Purchase the Report?
● To visualize the global home healthcare industry market segmentation based on offering, indication and region.
● Identify commercial opportunities by analyzing trends and co-development.
● Excel spreadsheet containing a comprehensive dataset of the home healthcare industry market, covering all levels of segmentation.
● PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
● Product mapping available as excel consisting of key products of all the major players.
The global home healthcare industry market report would provide approximately 46 tables, 35 figures and 201 pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Offering
3.2. Snippet by Indication
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological Advancements and Aging Population
4.1.1.2. Rising Healthcare Costs and Government Support
4.1.2. Restraints
4.1.2.1. Workforce Shortages and Regulatory Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. By Offering
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
6.1.2. Market Attractiveness Index, By Offering
6.2. Services*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.2.1. Physician primary care
6.2.2.2. Nursing care
6.2.2.3. Physical/occupational/speech therapy
6.2.2.4. Nutritional support
6.2.2.5. Unskilled Care
6.2.2.6. Others
6.3. Products
6.3.1. Introduction
6.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3.2.1. Therapeutic Products
6.3.2.2. Testing, Screening and Monitoring Products
6.3.2.3. Mobility Care Products
6.3.2.4. Others
7. By Indication
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
7.1.2. Market Attractiveness Index, By Indication
7.2. Cancer*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Neurological Disorders
7.4. Mobility Disorders
7.5. Diabetes
7.6. Cardiovascular Disorders
7.7. Others
8. Sustainability Analysis
8.1. Environmental Analysis
8.2. Economic Analysis
8.3. Governance Analysis
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. US
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Omron Healthcare, Inc*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. 3M
11.3. Air Liquide
11.4. B. Braun Melsungen AG
11.5. Linde plc
11.6. GE HealthCare
11.7. Koninklijke Philips N.V.,
11.8. Dickinson and Company
11.9. A&D Company Limited
11.10. Addus HomeCare Corporation.
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us
❖ 世界の在宅医療産業市場に関するよくある質問(FAQ) ❖
・在宅医療産業の世界市場規模は？
→DataM Intelligence社は2023年の在宅医療産業の世界市場規模を2,695億3,000万米ドルと推定しています。
・在宅医療産業の世界市場予測は？
→DataM Intelligence社は2031年の在宅医療産業の世界市場規模を4,742億5,000万米ドルと予測しています。
・在宅医療産業市場の成長率は？
→DataM Intelligence社は在宅医療産業の世界市場が2024年～2031年に年平均7.3%成長すると予測しています。
・世界の在宅医療産業市場における主要企業は？
→DataM Intelligence社は「Omron Healthcare, Inc, 3M, Air Liquide, B. Braun Melsungen AG, Linde plc, GE HealthCare, Koninklijke Philips N.V., Dickinson and Company, A&D Company Limited and Addus HomeCare Corporation.など ...」をグローバル在宅医療産業市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。
